150 related articles for article (PubMed ID: 21255185)
1. Microcystic/reticular schwannoma of the pancreas: a potential diagnostic pitfall.
Liegl B; Bodo K; Martin D; Tsybrovskyy O; Lackner K; Beham A
Pathol Int; 2011 Feb; 61(2):88-92. PubMed ID: 21255185
[TBL] [Abstract][Full Text] [Related]
2. Microcystic/reticular schwannoma: a distinct variant with predilection for visceral locations.
Liegl B; Bennett MW; Fletcher CD
Am J Surg Pathol; 2008 Jul; 32(7):1080-7. PubMed ID: 18520439
[TBL] [Abstract][Full Text] [Related]
3. Microcystic/reticular schwannoma of the esophagus: the first case report and a diagnostic pitfall.
Gu MJ; Choi JH
BMC Gastroenterol; 2014 Nov; 14():193. PubMed ID: 25404099
[TBL] [Abstract][Full Text] [Related]
4. Microcystic/Reticular Schwannoma of the Mandible First Case Report and Review of the Literature.
Yin Y; Wang T; Cai YP; Huang XJ; Li YJ; Chen SH; Qin R; Wang CF; Wu Q
Medicine (Baltimore); 2015 Nov; 94(45):e1974. PubMed ID: 26559274
[TBL] [Abstract][Full Text] [Related]
5. A phase II study of bevacizumab plus erlotinib for gemcitabine-refractory metastatic pancreatic cancer.
Ko AH; Venook AP; Bergsland EK; Kelley RK; Korn WM; Dito E; Schillinger B; Scott J; Hwang J; Tempero MA
Cancer Chemother Pharmacol; 2010 Nov; 66(6):1051-7. PubMed ID: 20130876
[TBL] [Abstract][Full Text] [Related]
6. [Medical-oncological aspects in the treatment of pancreatic cancer].
Heinemann V
Radiologe; 2009 Feb; 49(2):144-8. PubMed ID: 19048221
[TBL] [Abstract][Full Text] [Related]
7. Recent updates on the role of chemotherapy in pancreatic cancer.
Burris HA
Semin Oncol; 2005 Aug; 32(4 Suppl 6):S1-3. PubMed ID: 16143160
[TBL] [Abstract][Full Text] [Related]
8. Microcystic/reticular schwannoma of the proximal sigmoid colon: case report with review of literature.
Trivedi A; Ligato S
Arch Pathol Lab Med; 2013 Feb; 137(2):284-8. PubMed ID: 23368873
[TBL] [Abstract][Full Text] [Related]
9. Phase III trial of bevacizumab in combination with gemcitabine and erlotinib in patients with metastatic pancreatic cancer.
Van Cutsem E; Vervenne WL; Bennouna J; Humblet Y; Gill S; Van Laethem JL; Verslype C; Scheithauer W; Shang A; Cosaert J; Moore MJ
J Clin Oncol; 2009 May; 27(13):2231-7. PubMed ID: 19307500
[TBL] [Abstract][Full Text] [Related]
10. New directions in the management of advanced pancreatic cancer: a review.
Rocha-Lima CM
Anticancer Drugs; 2008 Jun; 19(5):435-46. PubMed ID: 18418211
[TBL] [Abstract][Full Text] [Related]
11. [The Clinical Efficacy of Neoadjuvant Chemotherapy for Borderline Resectable Pancreatic Carcinoma--Report of Two Cases Treated by Curative Pancreatectomy with Portal Vein Resection after Neoadjuvant Chemotherapy].
Imamura T; Ikoma H; Morimura R; Hatakeyama T; Kosuga T; Konishi H; Murayama Y; Komatsu S; Shiozaki A; Kuriu Y; Nakanishi M; Ichikawa D; Fujiwara H; Okamoto K; Ochiai T; Otsuji E
Gan To Kagaku Ryoho; 2015 Nov; 42(12):2379-81. PubMed ID: 26805370
[TBL] [Abstract][Full Text] [Related]
12. The combination of a chemotherapy doublet (gemcitabine and capecitabine) with a biological doublet (bevacizumab and erlotinib) in patients with advanced pancreatic adenocarcinoma. The results of a phase I/II study.
Watkins DJ; Starling N; Cunningham D; Thomas J; Webb J; Brown G; Barbachano Y; Oates J; Chau I
Eur J Cancer; 2014 May; 50(8):1422-9. PubMed ID: 24613126
[TBL] [Abstract][Full Text] [Related]
13. Palliative chemotherapy for pancreatic malignancies.
Mehta SP
Surg Clin North Am; 2010 Apr; 90(2):365-75. PubMed ID: 20362792
[TBL] [Abstract][Full Text] [Related]
14. SMARCB1/INI1 Loss in Epithelioid Schwannoma: A Clinicopathologic and Immunohistochemical Study of 65 Cases.
Jo VY; Fletcher CDM
Am J Surg Pathol; 2017 Aug; 41(8):1013-1022. PubMed ID: 28368924
[TBL] [Abstract][Full Text] [Related]
15. Microcystic/reticular Schwannoma: morphological features causing diagnostic dilemma on fine-needle aspiration cytology.
Gong S; Hafez-Khayyata S; Xin W
Am J Case Rep; 2014 Dec; 15():538-42. PubMed ID: 25472470
[TBL] [Abstract][Full Text] [Related]
16. Dose finding and early efficacy study of gemcitabine plus capecitabine in combination with bevacizumab plus erlotinib in advanced pancreatic cancer.
Starling N; Watkins D; Cunningham D; Thomas J; Webb J; Brown G; Thomas K; Oates J; Chau I
J Clin Oncol; 2009 Nov; 27(33):5499-505. PubMed ID: 19858399
[TBL] [Abstract][Full Text] [Related]
17. Microcystic/Reticular Schwannoma Arising in the Submandibular Gland: A Rare Benign Entity that Mimics More Common Salivary Gland Carcinomas.
Lau RP; Melamed J; Yee-Chang M; Marcus S; Givi B; Zamuco R
Head Neck Pathol; 2016 Sep; 10(3):374-8. PubMed ID: 26621673
[TBL] [Abstract][Full Text] [Related]
18. Phase II study of gemcitabine and erlotinib as adjuvant therapy for patients with resected pancreatic cancer.
Bao PQ; Ramanathan RK; Krasinkas A; Bahary N; Lembersky BC; Bartlett DL; Hughes SJ; Lee KK; Moser AJ; Zeh HJ
Ann Surg Oncol; 2011 Apr; 18(4):1122-9. PubMed ID: 21104328
[TBL] [Abstract][Full Text] [Related]
19. Resection of metachronous pancreatic cancer 4 years after pancreaticoduodenectomy for stage III pancreatic adenocarcinoma.
Hamner JB; White M; Crowder C; Singh G
World J Surg Oncol; 2015 Sep; 13():290. PubMed ID: 26419361
[TBL] [Abstract][Full Text] [Related]
20. The combination of epidermal growth factor receptor inhibitors with gemcitabine and radiation in pancreatic cancer.
Morgan MA; Parsels LA; Kollar LE; Normolle DP; Maybaum J; Lawrence TS
Clin Cancer Res; 2008 Aug; 14(16):5142-9. PubMed ID: 18698032
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
